BU Today: Trustee Gives $10 Million to Redirect Fight against Prostate Cancer
Shipley Foundation gift will fund research in personalized medicine
Each year, more than 100,000 men diagnosed with prostate cancer in the United States undergo a prostatectomy, a surgical procedure that leaves most of them unable to function sexually and many of them incontinent. The majority would live just as long with no treatment at all.
It’s “Dark Ages” medicine, says Richard C. Shipley (Questrom’68,’72), who was diagnosed with prostate cancer 18 months ago and eventually sought out a new, less invasive treatment, called focal laser ablation. The successful technology investor and former CEO wants to see such humane, high-tech treatment become the norm for all men with prostate cancer. To help that happen, the BU trustee is giving the School of Medicine $10.5 million to create a prostate cancer research center on the Medical Campus and a website with information about treatment options.
Continue reading at: https://www.bu.edu/today/